Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate 43975-0279
Product NDC
43975-0279- Manufacturer
- Ani Pharmaceuticals, Inc.
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- March 16, 2020
- Listing Expires
- December 31, 2027
- Application
- ANDA205401
Active Ingredients
| Ingredient | Strength |
|---|---|
| Amphetamine Dl-Aspartate Monohydrate | 3.75 mg/1 |
| Amphetamine Sulfate | 3.75 mg/1 |
| Dextroamphetamine Saccharate | 3.75 mg/1 |
| Dextroamphetamine Sulfate | 3.75 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]
Packaging Options(1)
100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43975-279-10)